Coronary revascularization does not improve echocardiographic ejection fraction or serum NT-proBNP levels but may improve left ventricular diastolic function in patients with developed heart failure.
Comparison of eplerenone and spyronolacton effects in prevention of left ventricular remodeling and development of heart failure in patients after STEMI